What's Happening?
GenScript Biotech Corporation announced that its CEO Sherry Shao and Co-Founder Dr. Frank Zhang have been selected as finalists for the Entrepreneur Of The Year 2026 New Jersey Award by Ernst & Young LLP. This prestigious program recognizes visionary
leaders who build and sustain successful businesses through innovation, growth, resilience, and long-term impact. Founded in New Jersey in 2002, GenScript has evolved from a pioneering gene synthesis company into a global biotechnology enterprise. The recognition highlights the entrepreneurial leadership of Dr. Zhang and Sherry Shao, who have guided the company through significant global growth and transformation.
Why It's Important?
The recognition of GenScript's leaders as finalists for the Entrepreneur Of The Year award underscores the company's significant contributions to the biotechnology industry. GenScript's growth from a gene synthesis company to a global biotechnology enterprise reflects its impact on research, therapeutics, and industrial applications. This acknowledgment not only highlights the company's innovative approach but also its role in advancing biotechnology to create meaningful value for customers, patients, and society. The award serves as a testament to the company's commitment to scientific innovation and its potential to shape a healthier future.
What's Next?
The regional award winners will be announced at the Entrepreneur Of The Year 2026 New Jersey Awards celebration on June 4, 2026. If GenScript's leaders win, it could further enhance the company's reputation and influence in the biotechnology sector. The recognition may also open up new opportunities for partnerships and collaborations, potentially accelerating GenScript's mission to make biotechnology more accessible and efficient. The company's continued focus on innovation and growth could lead to further advancements in life science services and products, benefiting researchers, biotechnology innovators, and pharmaceutical companies worldwide.
